SCHEMBL4430343

SCHEMBL4430343

C=CCc1oc2ccccc2c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EYA3 Q99504 4/20 0.44
SLC22A12 Q96S37 2/20 0.44
CYP2C19 P33261 5/20 0.42
TTR P02766 4/20 0.42
CYP2C9 P11712 3/20 0.42
LMNA P02545 3/20 0.42
PTGS1 P23219 2/20 0.42
MEN1 O00255 2/20 0.42
ABCB11 O95342 2/20 0.42
PGR P06401 2/20 0.42
ADRA2A P08913 2/20 0.42
TBXA2R P21731 2/20 0.42
OPRM1 P35372 2/20 0.42
SLC6A3 Q01959 2/20 0.42
KMT2A Q03164 2/20 0.42
BIRC5 O15392 1/20 0.42
HTR1A P08908 1/20 0.42
DRD1 P21728 1/20 0.42
SLC6A2 P23975 1/20 0.42
PDE4A P27815 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9267705 0.89 EYA3 (0.55) EYA3SLC22A12CYP2C19TTRCYP2C9
SCHEMBL9605230 0.88 EYA3 (0.43) EYA3SLC22A12CYP2C19TTRCYP2C9
SCHEMBL2141567 0.83 EYA3 (0.69) EYA3SLC22A12CYP2C19TTRCYP2C9
SCHEMBL4670184 0.80 EYA3 (0.66) EYA3SLC22A12CYP2C19TTRCYP2C9
Hydrochloric Acid SCHEMBL9350957 0.79 EYA3 (0.64) EYA3SLC22A12CYP2C19TTRCYP2C9
SCHEMBL10599107 0.79 CYP2C19 (0.63) EYA3SLC22A12CYP2C19CYP2C9MEN1
SCHEMBL10602010 0.78 CYP2C19 (0.46) EYA3SLC22A12CYP2C19TTRCYP2C9
SCHEMBL10598815 0.77 EYA3 (0.54) EYA3SLC22A12CYP2C19CYP2C9PTPN1
Hydrochloric Acid SCHEMBL9347221 0.76 CYP2C9 (0.58) EYA3SLC22A12CYP2C19TTRCYP2C9
SCHEMBL9287304 0.76 EYA3 (0.53) EYA3SLC22A12CYP2C19TTRCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1699772-B1 PROCESS FOR THE PREPERATION OF N-ALKYL-2(HYDROXY-4 BENZOYL)-3 BENZOFURANS AND ITS INTERMEDIATES THEREOF CLARIANT SPECIALTY FINE CHEM F (FR) 2013-02-20 EP claimed
EP-2508517-A1 Process for the preparation of N-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and its intermediates thereof Clariant Specialty Fine Chemicals (France) (FR) 2012-10-10 EP claimed
US-7544817-B2 Process for the preparation of n-alkyl-2(hydroxy-4benzoyl)-3 benzofurans and intermediates thereof CLARIANT (FRANCE) (FR) 2009-06-09 US claimed
US-20070155831-A1 Process for the preparation of n-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and its intermediates thereof WEYLCHEM LAMOTTE S.A.S. (FR) 2007-07-05 US claimed
EP-1699772-A1 PROCESS FOR THE PREPERATION OF N-ALKYL-2(HYDROXY-4 BENZOYL)-3 BENZOFURANS AND ITS INTERMEDIATES THEREOF Clariant (France) S.A. (FR) 2006-09-13 EP claimed
WO-2005066149-A1 PROCESS FOR THE PREPERATION OF N-ALKYL-2(HYDROXY-4 BENZOYL)-3 BENZOFURANS AND ITS INTERMEDIATES THEREOF CLARIANT (FRANCE) (FR) 2005-07-21 WO claimed
EP-1699772-B1 PROCESS FOR THE PREPERATION OF N-ALKYL-2(HYDROXY-4 BENZOYL)-3 BENZOFURANS AND ITS INTERMEDIATES THEREOF CLARIANT SPECIALTY FINE CHEM F (FR) 2013-02-20 EP disclosed
EP-2508517-A1 Process for the preparation of N-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and its intermediates thereof Clariant Specialty Fine Chemicals (France) (FR) 2012-10-10 EP disclosed
US-7544817-B2 Process for the preparation of n-alkyl-2(hydroxy-4benzoyl)-3 benzofurans and intermediates thereof CLARIANT (FRANCE) (FR) 2009-06-09 US disclosed
US-20070155831-A1 Process for the preparation of n-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and its intermediates thereof WEYLCHEM LAMOTTE S.A.S. (FR) 2007-07-05 US disclosed
EP-1699772-A1 PROCESS FOR THE PREPERATION OF N-ALKYL-2(HYDROXY-4 BENZOYL)-3 BENZOFURANS AND ITS INTERMEDIATES THEREOF Clariant (France) S.A. (FR) 2006-09-13 EP disclosed
WO-2005066149-A1 PROCESS FOR THE PREPERATION OF N-ALKYL-2(HYDROXY-4 BENZOYL)-3 BENZOFURANS AND ITS INTERMEDIATES THEREOF CLARIANT (FRANCE) (FR) 2005-07-21 WO disclosed
EP-0380588-B1 CERTAIN 3-SUBSTITUTED 2-ALKYL BENZOFURAN DERIVATIVES RES CORP TECHNOLOGIES INC (US) 1994-11-09 EP disclosed
US-5266711-A Process for the preparation of 3-benzoyl benzofuran derivatives SANOFI (FR) 1993-11-30 US disclosed
EP-0380588-A4 CERTAIN 3-SUBSTITUTED 2-ALKYL BENZOFURAN DERIVATIVES 1991-04-03 EP disclosed
EP-0380588-A1 CERTAIN 3-SUBSTITUTED 2-ALKYL BENZOFURAN DERIVATIVES. UNIV TENNESSEE RES CORP (US) 1990-08-08 EP disclosed
US-4851554-A Certain 3-substituted 2-alkyl benzofuran derivatives UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 1989-07-25 US disclosed
WO-1989002892-A1 CERTAIN 3-SUBSTITUTED 2-ALKYL BENZOFURAN DERIVATIVES THE UNIVERSITY OF TENNESSEE RESEARCH CORPORATION (US) 1989-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155831-A1 Process for the preparation of n-alkyl-2(hydroxy-4 benzoyl)-3 benzofurans and its intermediates thereof CYP2F1, CYP2E1, CYP1B1 EYA3 4838/4885SLC22A12 3418/4885CYP2C19 46/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.